Pulsed Electromagnetic Versus Hydrotherapy on Chronic Pelvic Pain
PEMF
Effect of Pulsed Electromagnetic Field Versus Hydrotherapy on Chronic Pelvic Pain Syndrome: A Randomized Controlled Trial
1 other identifier
interventional
300
1 country
1
Brief Summary
Pulsed electromagnetic field therapy and hydrotherapy are non-invasive treatment modalities that may alleviate chronic pelvic pain through pain modulation, reduction of inflammation, enhancement of circulation, and relaxation of pelvic musculature. Both interventions have demonstrated potential benefits in reducing pain severity and improving functional outcomes and quality of life in patients with chronic pelvic pain syndrome, supporting their investigation as therapeutic options in clinical research
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 20, 2026
CompletedFirst Submitted
Initial submission to the registry
October 5, 2026
CompletedFirst Posted
Study publicly available on registry
October 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2026
October 9, 2026
October 1, 2026
3 months
October 5, 2026
October 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
chronic pelvic pain
will be measured by visual analogue scale interpreting pain intensity with minimum score = 0 and maximum score = 10, and lower scores means a better improvement
12 weeks
Secondary Outcomes (1)
participants quality of life
12 weeks
Study Arms (3)
Study Group I
EXPERIMENTALPulsed electromagnetic field and traditional program in the form of pelvic floor muscle training
Study Group II
EXPERIMENTALhydrotherapy and traditional program in the form of pelvic floor muscle training
Control group
EXPERIMENTALtraditional program in the form of pelvic floor muscle training
Interventions
Participants allocated to the experimental group will receive pulsed electromagnetic field therapy using a low-frequency PEMF device applied over the suprapubic and perineal regions. Participants will be positioned comfortably in a supine lying position during treatment. The electromagnetic field will be delivered at therapeutic frequencies and intensities according to the manufacturer's recommendations for pain management and soft tissue healing. Each treatment session will last approximately 20-30 minutes, administered three sessions per week for 12 weeks.
Participants allocated to the hydrotherapy group will undergo a supervised aquatic exercise program conducted in a therapeutic pool with warm water maintained at 32-34°C. Each session will last approximately 45-60 minutes, three times per week for 12 weeks. The intervention will include gentle warm-up exercises, pelvic mobility exercises, stretching, relaxation techniques, and low-to-moderate intensity aerobic and strengthening activities performed in water.
The intervention will be administered by a licensed physiotherapist and will consist of pelvic floor muscle awareness training, relaxation exercises, diaphragmatic breathing, stretching exercises, and controlled pelvic floor muscle contractions. Treatment sessions will be conducted three times per week for 12 weeks, with each session lasting approximately 30-45 minutes. Participants will also be instructed to perform a structured home exercise program on non-treatment days
Eligibility Criteria
You may qualify if:
- male patients aged 42 - 50 years
- chronic non bacterial prostatitis
- Diagnosis of Chronic Non-Bacterial Prostatitis/Chronic Pelvic Pain Syndrome (NIH Category III) confirmed by a urologist.
- Presence of pelvic, perineal, suprapubic, testicular, penile, or ejaculatory pain for at least 3 months within the previous 6 months.
- Stable medical treatment for at least 4 weeks before enrollment, if receiving medications.
- Ability to understand study procedures and provide written informed consent. Willingness to refrain from initiating new treatments for prostatitis during the study period.
You may not qualify if:
- Diagnosis of acute bacterial prostatitis
- History of prostate cancer, bladder cancer, or other pelvic malignancy
- Previous prostate surgery within the last 12 months
- Contraindications to hydrotherapy, including: Open wounds, Active skin infections, Uncontrolled epilepsy, Severe cardiac insufficiency
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Horus Universitylead
Study Sites (1)
Horus University in Egypt
Amman, 130, Jordan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- computer based and using sealed envelopes
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor of Physical Therapy for Surgery and Burn
Study Record Dates
First Submitted
October 5, 2026
First Posted
October 9, 2026
Study Start
July 20, 2026
Primary Completion (Estimated)
October 30, 2026
Study Completion (Estimated)
November 30, 2026
Last Updated
October 9, 2026
Record last verified: 2026-10
Data Sharing
- IPD Sharing
- Will not share
not be shared